收费全文 | 12634篇 |
免费 | 757篇 |
国内免费 | 26篇 |
耳鼻咽喉 | 97篇 |
儿科学 | 381篇 |
妇产科学 | 187篇 |
基础医学 | 1579篇 |
口腔科学 | 400篇 |
临床医学 | 1347篇 |
内科学 | 2460篇 |
皮肤病学 | 159篇 |
神经病学 | 1207篇 |
特种医学 | 350篇 |
外科学 | 1991篇 |
综合类 | 101篇 |
一般理论 | 9篇 |
预防医学 | 843篇 |
眼科学 | 302篇 |
药学 | 1063篇 |
中国医学 | 24篇 |
肿瘤学 | 917篇 |
2023年 | 98篇 |
2022年 | 48篇 |
2021年 | 197篇 |
2020年 | 220篇 |
2019年 | 312篇 |
2018年 | 296篇 |
2017年 | 279篇 |
2016年 | 310篇 |
2015年 | 303篇 |
2014年 | 431篇 |
2013年 | 671篇 |
2012年 | 884篇 |
2011年 | 889篇 |
2010年 | 475篇 |
2009年 | 470篇 |
2008年 | 800篇 |
2007年 | 839篇 |
2006年 | 786篇 |
2005年 | 712篇 |
2004年 | 696篇 |
2003年 | 661篇 |
2002年 | 599篇 |
2001年 | 134篇 |
2000年 | 101篇 |
1999年 | 137篇 |
1998年 | 148篇 |
1997年 | 124篇 |
1996年 | 86篇 |
1995年 | 105篇 |
1994年 | 106篇 |
1993年 | 83篇 |
1992年 | 82篇 |
1991年 | 94篇 |
1990年 | 88篇 |
1989年 | 86篇 |
1988年 | 69篇 |
1987年 | 71篇 |
1986年 | 75篇 |
1985年 | 88篇 |
1984年 | 74篇 |
1983年 | 65篇 |
1982年 | 101篇 |
1981年 | 61篇 |
1980年 | 52篇 |
1979年 | 52篇 |
1978年 | 39篇 |
1977年 | 33篇 |
1976年 | 35篇 |
1975年 | 24篇 |
1974年 | 26篇 |
Background
Health-related quality of life (HRQoL) is frequently assessed in randomised clinical trials (RCTs) in the intensive care unit (ICU), but data are limited regarding the proportions of patients without responses or not surviving to HRQoL follow-up and the handling of this. We aimed to describe the extent and pattern of missing HRQoL data in intensive care trials and describe how these data and deaths were handled statistically.Methods
We conducted a systematic review and meta-analysis following a published protocol. We searched PubMed, EMBASE, CINAHL and Cochrane Library for RCTs involving adult ICU patients reporting HRQoL as an outcome and excluded RCTs unobtainable in full text. We performed risk of bias assessment independently and in duplicate.Results
We included 196 outcomes from 88 RCTs published in the years 2002–2022; the numbers of patients alive and eligible to respond HRQoL were reported in 76% of trials. At follow-up, median 27% (interquartile range 14%–39%) of patients had died, and median 20% (9%–38%) of survivors did not respond across outcomes. Analyses of 80% of outcomes were restricted to complete cases only. The handling of non-survivors in analyses were reported for 46% of outcomes, with 26% of all outcomes reported as including non-survivors (using the value zero or the worst possible score).Conclusion
For HRQoL outcomes in ICU trials, we found that mortality at time of follow-up was high and non-response among survivors frequent. The reporting and statistical handling of these issues were insufficient, which may have biased results. 相似文献Background
Salt and water accumulation leading to fluid overload is associated with increased mortality in intensive care unit (ICU) patients, but diuretics' effects on patient outcomes are uncertain. In this first version of the GODIF trial, we aimed to assess the effects of goal-directed fluid removal with furosemide versus placebo in adult ICU patients with fluid overload.Methods
We conducted a multicentre, randomised, stratified, parallel-group, blinded, placebo-controlled trial in clinically stable, adult ICU patients with at least 5% fluid overload. Participants were randomised to furosemide versus placebo infusion aiming at achieving neutral cumulative fluid balance as soon as possible. The primary outcome was the number of days alive and out of the hospital at 90 days.Results
The trial was terminated after the enrolment of 41 of 1000 participants because clinicians had difficulties using cumulative fluid balance as the only estimate of fluid status (32% of participants had their initially registered cumulative fluid balance adjusted and 29% experienced one or more protocol violations). The baseline cumulative fluid balance was 6956 ml in the furosemide group and 6036 ml in the placebo group; on day three, the cumulative fluid balances were 1927 ml and 5139 ml. The median number of days alive and out of hospital at day 90 was 50 days in the furosemide group versus 45 days in the placebo group (mean difference 1 day, 95% CI -19 to 21, p-value .94).Conclusions
The use of cumulative fluid balance as the only estimate of fluid status appeared too difficult to use in clinical practice. We were unable to provide precise estimates for any outcomes as only 4.1% of the planned sample size was randomised. 相似文献Patients and methods: A structured medical record follow-up was performed on the subgroup of patients without watery diarrhoea but diagnosed with the typical CC histologic appearance in a previous study of microscopic colitis.
Results: At follow up after a median time of 8 years (range: 0.33–12 years), five of these fifteen patients developed bowel symptoms but only two developed characteristic CC symptoms with watery diarrhoea.
Conclusion: The majority of patients without chronic watery diarrhoea at diagnosis remained free from this symptom during follow up and only in a few cases symptoms attributed to CC developed. 相似文献